These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29027812)

  • 41. Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction.
    Lind M; Jendle J; Torffvit O; Lager I
    Prim Care Diabetes; 2012 Apr; 6(1):41-6. PubMed ID: 22015237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diabetes distress and its association with clinical outcomes in patients with type 2 diabetes treated with pramlintide as an adjunct to insulin therapy.
    Peyrot M; Rubin RR; Polonsky WH
    Diabetes Technol Ther; 2008 Dec; 10(6):461-6. PubMed ID: 19049375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: An open label, prospective, multicenter trial in Japan.
    Ogawa W; Hirota Y; Osonoi T; Tosaki T; Kato Y; Utsunomiya K; Nishimura R; Nakamura J
    J Diabetes Investig; 2021 Jan; 12(1):82-90. PubMed ID: 32562376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
    Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
    Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of blinded retrospective continuous glucose monitoring on clinical decision making and glycemic control in persons with type 2 diabetes on insulin therapy.
    Ribeiro RT; Andrade R; Nascimento do Ó D; Lopes AF; Raposo JF
    Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1267-1275. PubMed ID: 33612381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs.
    Peyrot M; Rubin RR; Polonsky WH; Best JH
    Curr Med Res Opin; 2010 May; 26(5):1047-54. PubMed ID: 20199136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using the Internet-based upload blood glucose monitoring and therapy management system in patients with type 1 diabetes.
    Shalitin S; Ben-Ari T; Yackobovitch-Gavan M; Tenenbaum A; Lebenthal Y; de Vries L; Phillip M
    Acta Diabetol; 2014 Apr; 51(2):247-56. PubMed ID: 23982170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials.
    Polonsky W; Traylor L; Gao L; Wei W; Ameer B; Stuhr A; Vlajnic A
    J Diabetes Complications; 2017 Mar; 31(3):562-568. PubMed ID: 28040350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus.
    Peyrot M; Rubin RR; Chen X; Frias JP
    Diabetes Technol Ther; 2011 Apr; 13(4):471-6. PubMed ID: 21355725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Better treatment of outpatients with type 1 diabetes after introduction of continuous subcutaneous insulin infusion.
    Marmolin ES; Brødsgaard J; Gjessing HJ; Schousboe K; Grodum E; Jørgensen UL; Møller CC; Pedersen J
    Dan Med J; 2012 Jun; 59(6):A4445. PubMed ID: 22677243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once-daily injection in patients with well-controlled type 2 diabetes.
    Inoue Y; Nakamura A; Kondo Y; Hamano K; Satoh S; Terauchi Y
    J Clin Pharmacol; 2015 Jul; 55(7):831-8. PubMed ID: 25677642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes.
    Halbron M; Bourron O; Andreelli F; Ciangura C; Jacqueminet S; Popelier M; Bosquet F; Rouanet S; Amouyal C; Hartemann A
    Diabetes Technol Ther; 2019 Jul; 21(7):409-412. PubMed ID: 31265349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel simple insulin delivery device reduces barriers to insulin therapy in type 2 diabetes: results from a pilot study.
    Hermanns N; Lilly LC; Mader JK; Aberer F; Ribitsch A; Kojzar H; Warner J; Pieber TR
    J Diabetes Sci Technol; 2015 May; 9(3):581-7. PubMed ID: 25670847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic β-cell function in type 1 diabetes.
    Thrailkill KM; Moreau CS; Swearingen C; Rettiganti M; Edwards K; Morales AE; Kemp SF; Frindik JP; Fowlkes JL
    Diabetes Technol Ther; 2011 Oct; 13(10):1023-30. PubMed ID: 21718094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software.
    Garg SK; Bookout TR; McFann KK; Kelly WC; Beatson C; Ellis SL; Gutin RS; Gottlieb PA
    Diabetes Technol Ther; 2008 Oct; 10(5):369-75. PubMed ID: 18715213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: a Belgian experience.
    Dorchy H; Roggemans MP; Willems D
    Diabetes Care; 1997 Jan; 20(1):2-6. PubMed ID: 9028684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment satisfaction after commencement of insulin in Type 2 diabetes.
    Wilson M; Moore MP; Lunt H
    Diabetes Res Clin Pract; 2004 Dec; 66(3):263-7. PubMed ID: 15536023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.
    Aronson R; Cohen O; Conget I; Runzis S; Castaneda J; de Portu S; Lee S; Reznik Y;
    Diabetes Technol Ther; 2014 Jul; 16(7):414-20. PubMed ID: 24735134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.